Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Decker

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|March 16, 1973
Volcanism in Mexico and central americaR W Decker
Hospital Purchasing Management|December 13, 1978
Is buyer forced to accept low bid?R W Decker
Biochemical Pharmacology|December 1, 1976
Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347)N S Mizuno, R W Decker
Biochemical Pharmacology|March 1, 1975
Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388)N S Mizuno, R W Decker, B Zakis
Cancer Research|June 1, 1975
Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesisN S Mizuno, B Zakis, R W Decker
Science (New York, N.Y.)|August 6, 1971
Rifting in iceland: new geodetic dataR W Decker, P Einarsson, P A Mohr
Biochimica Et Biophysica Acta|November 1, 1976
Incorporation of tritium-labeled thymidine monophosphate into nuclear DNA by permeabilized yeast cellsW S Yee, R W Decker, C F Brunk
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1989
Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamineD Malejka-Giganti, W J Magat, R W Decker
Cancer Treatment Reports|September 1, 1987
Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemiaR W Decker, W G Ho, R E Champlin
Biochemical Pharmacology|November 15, 1983
Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating ratsD Malejka-Giganti, R W Decker, C L Ritter
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|March 16, 1973
Volcanism in Mexico and central americaR W Decker
Hospital Purchasing Management|December 13, 1978
Is buyer forced to accept low bid?R W Decker
Biochemical Pharmacology|December 1, 1976
Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347)N S Mizuno, R W Decker
Biochemical Pharmacology|March 1, 1975
Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388)N S Mizuno, R W Decker, B Zakis
Cancer Research|June 1, 1975
Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesisN S Mizuno, B Zakis, R W Decker
Science (New York, N.Y.)|August 6, 1971
Rifting in iceland: new geodetic dataR W Decker, P Einarsson, P A Mohr
Biochimica Et Biophysica Acta|November 1, 1976
Incorporation of tritium-labeled thymidine monophosphate into nuclear DNA by permeabilized yeast cellsW S Yee, R W Decker, C F Brunk
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1989
Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamineD Malejka-Giganti, W J Magat, R W Decker
Cancer Treatment Reports|September 1, 1987
Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemiaR W Decker, W G Ho, R E Champlin
Biochemical Pharmacology|November 15, 1983
Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating ratsD Malejka-Giganti, R W Decker, C L Ritter
Pageof 2